Evofem Biosciences, Inc. (EVFM)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Show:
Annual
Cash Flow
All numbers in thousandsBreakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Cash flows from operating activities
Net Income
-194,236
-142,309
-80,033
-125,712
-9,993
Depreciation & amortization
859
302
263
262
45.87
Stock based compensation
9,173
12,697
8,579
17,842
759.329
Change in working capital
-9,297
-15,227
-12,673
3,058
930.943
Accounts receivable
-2,788
-1,067
-
-
-
Inventory
-5,006
-6,010
-
-
-
Accounts Payable
1,379
4,126
-2,931
3,799
509.829
Other working capital
-168,788
-107,083
-55,261
-56,507
-8,201
Other non-cash items
4,593
2,940
642
-
-
Net cash provided by operating activites
-164,481
-104,829
-55,097
-56,500
-8,201
Cash flows from investing activities
Investments in property, plant and equipment
-4,307
-2,254
-164
-7
-
Purchases of investments
-
0
-8,233
-
-
Sales/Maturities of investments
0
8,233
-
-
-
Net cash used for investing activites
-4,057
6,229
-8,115
2,143
7.1
Cash flows from financing activities
Debt repayment
-
0
-4,010
-
0
Common stock issued
81,534
107,519
78,360
57,542
-
Dividends Paid
-
-
0
-157
-
Other financing activites
-1,255
-3,742
-2,852
-3,010
-
Net cash used privided by (used for) financing activities
105,744
154,226
78,076
54,417
26.349
Net change in cash
-62,794
55,626
14,864
60
-8,168
Cash at beginning of period
87,834
16,625
1,761
1,701
11,678
Cash at end of period
25,040
72,251
16,625
1,761
3,510
Free Cash Flow
Operating Cash Flow
-164,481
-104,829
-55,097
-56,500
-8,201
Capital Expenditure
-4,307
-2,254
-164
-7
-
Free Cash Flow
-168,788
-107,083
-55,261
-56,507
-8,201
